Expertise in
2
conditions

Miriam P. Rosin

8888 University Dr, V5A 1S6, 
Burnaby, BC, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
2
conditions
8888 University Dr, V5A 1S6, 
Burnaby, BC, CA 

Overview

Miriam Rosin practices practicing medicine in Burnaby, Canada.

Ms. Rosin is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Leukoplakia, Erythroplakia, Lichen Planus, and High Blood Pressure in Infants.

She is actively involved in clinical research, co-authoring 74 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

8888 University Dr, V5A 1S6, Burnaby, BC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase II Randomized, Double Blind, Placebo-Controlled Trial of Broccoli Seed and Sprout Extract (BSSE), Avmacol ES, to Evaluate Sustained Detoxification of Tobacco Carcinogens in Heavy Smokers
Phase II Randomized, Double Blind, Placebo-Controlled Trial of Broccoli Seed and Sprout Extract (BSSE), Avmacol ES, to Evaluate Sustained Detoxification of Tobacco Carcinogens in Heavy Smokers
Enrollment Status: Recruiting
Publish Date: July 14, 2026
Intervention Type: Drug, Dietary supplement, Procedure, Other
Study Phase: Phase 2
M4OC-Prevent 2.0: Phase IIb Trial of Metformin for Oral Cancer Prevention
M4OC-Prevent 2.0: Phase IIb Trial of Metformin for Oral Cancer Prevention
Enrollment Status: Active_not_recruiting
Publish Date: September 02, 2026
Intervention Type: Drug, Procedure
Study Drug: Metformin Hydrochloride
Study Phase: Phase 2
M4OC-Prevent: Metformin for Oral Cancer Prevention
M4OC-Prevent: Metformin for Oral Cancer Prevention
Enrollment Status: Active_not_recruiting
Publish Date: June 26, 2026
Intervention Type: Drug, Other
Study Drug: Metformin Hydrochloride
Study Phase: Phase 2
View 2 Less Clinical Trial

74 Total Publications

Clinical Features Associated With Malignant Transformation of Low-Grade Dysplasia.
Clinical Features Associated With Malignant Transformation of Low-Grade Dysplasia.
Journal: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
Published: December 04, 2024

Frequently Asked Questions about Miriam P. Rosin

Is Miriam P. Rosin a top-rated expert for Leukoplakia?

MediFind is an objective health platform that identifies experts based on real-world data. Miriam P. Rosin is classified as an Advanced expert for Leukoplakia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Miriam P. Rosin participate in research or clinical trials?

Yes. Miriam P. Rosin has published 74 articles and abstracts on conditions like Leukoplakia. You can view a list of Miriam P. Rosin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Rosin's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile